Reunion Neuroscience : Provides 2023 Corporate Update - Form 6-K
Reunion Neuroscience Inc. Provides 2023 Corporate Update Company Plans to Report Phase 1 Interim Analysis for RE104 in Q1 2023 and Include Data Differentiating its Safety,... | January 4, 2023
United States San Francisco Greg Mayes Shana Marino Company Plans To Report Phase Neither The Toronto Stock Exchange
Source: marketscreener.com